Dolby Laboratories (DLB) Reports Q4 Earnings: What Key Metrics Have to Say
Werte in diesem Artikel
For the quarter ended September 2024, Dolby Laboratories (DLB) reported revenue of $304.81 million, up 4.9% over the same period last year. EPS came in at $0.81, compared to $0.65 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $305.82 million, representing a surprise of -0.33%. The company delivered an EPS surprise of +19.12%, with the consensus EPS estimate being $0.68.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Products and services: $22.10 million versus $25.61 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -12.9% change. Revenue- Licensing: $282.71 million compared to the $280.21 million average estimate based on three analysts. The reported number represents a change of +6.6% year over year. Gross Margin- Licensing: $263.94 million compared to the $265.12 million average estimate based on three analysts. Gross margin- Products and services: $6.87 million versus $3.25 million estimated by three analysts on average. View all Key Company Metrics for Dolby Laboratories here>>>Shares of Dolby Laboratories have returned -3.9% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dolby Laboratories (DLB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Dolby Laboratories
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Dolby Laboratories
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Dolby Laboratories Inc.
Analysen zu Dolby Laboratories Inc.
Datum | Rating | Analyst | |
---|---|---|---|
02.08.2019 | Dolby Laboratories Neutral | B. Riley FBR | |
25.10.2018 | Dolby Laboratories Neutral | B. Riley FBR | |
05.09.2018 | Dolby Laboratories Buy | R. F. Lafferty | |
26.07.2018 | Dolby Laboratories Neutral | B. Riley FBR | |
16.01.2018 | Dolby Laboratories Neutral | B. Riley FBR, Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
05.09.2018 | Dolby Laboratories Buy | R. F. Lafferty | |
28.04.2016 | Dolby Laboratories Buy | Dougherty & Company LLC | |
25.04.2016 | Dolby Laboratories Buy | Dougherty & Company LLC | |
28.03.2016 | Dolby Laboratories Buy | Dougherty & Company LLC | |
28.01.2016 | Dolby Laboratories Buy | Dougherty & Company LLC |
Datum | Rating | Analyst | |
---|---|---|---|
02.08.2019 | Dolby Laboratories Neutral | B. Riley FBR | |
25.10.2018 | Dolby Laboratories Neutral | B. Riley FBR | |
26.07.2018 | Dolby Laboratories Neutral | B. Riley FBR | |
16.01.2018 | Dolby Laboratories Neutral | B. Riley FBR, Inc. | |
22.01.2015 | Dolby Laboratories Neutral | B. Riley & Co., LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dolby Laboratories Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen